Clinical Trials Directory

Trials / Completed

CompletedNCT04558515

Automated Microscopy Evaluation Study

Clinical Evaluation of Automated Microscope Solutions for Malaria Diagnosis

Status
Completed
Phase
Study type
Observational
Enrollment
190 (actual)
Sponsor
Foundation for Innovative New Diagnostics, Switzerland · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

Since the introduction of Giemsa stain in 1904 until today, malaria microscopy has been the standard of practice for malaria diagnosis. However, microscopic detection of malaria parasites is labour-intensive, time-consuming and expertise-demanding. Moreover, the slide interpretation is highly dependent on the staining technique and the technician's expertise. To address these, multiple organisations have developed next generation microscopes to move towards a next generation microscope that can improve slide preparation, interpretation or data collection, or a combination of these features. In this study, a prospective evaluation of miLab™ and other next generation automated microscope solutions as well as a malaria rapid diagnostic test (RDT) reader app will be performed in malaria-endemic countries to assess their clinical performance for detection of malaria clinical cases at POC.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNovel malaria diagnostics & toolsNext generation microscopy tools for malaria diagnosis and medical applications

Timeline

Start date
2020-02-01
Primary completion
2021-07-01
Completion
2021-12-31
First posted
2020-09-22
Last updated
2023-11-18

Locations

1 site across 1 country: Sudan

Source: ClinicalTrials.gov record NCT04558515. Inclusion in this directory is not an endorsement.